Skip to main content

Mouse CDO Antibody

R&D Systems, part of Bio-Techne | Catalog # AF2429

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
AF2429
AF2429-SP

Key Product Details

Species Reactivity

Validated:

Mouse

Cited:

Mouse, Transgenic Mouse, Zebrafish

Applications

Validated:

Immunohistochemistry, Western Blot

Cited:

Immunocytochemistry, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse CDO
Val22-Leu963
Accession # AAC43031

Specificity

Detects mouse CDO in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Mouse CDO Antibody

Detection of Mouse CDO antibody by Western Blot.

Detection of Mouse CDO by Western Blot.

Western blot shows lysate of C2C12 mouse myoblast cell line. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Mouse CDO Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2429) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for CDO at approximately 190 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Mouse CDO by Knockdown Validated

Detection of Mouse CDO by Knockdown Validated

PKN2 levels are elevated during myoblast differentiation and decreased in Cdo-depleted cells with a concurrent reduction in AKT activation. (a) C2C12 cells were cultured to near confluency (D0) and induced to differentiate in differentiation medium (DM) for total 3 days (D3). Lysates were immunoblotted with antibodies to PKN2, Cdo, MHC, MyoD, myogenin, phosphorylated-AKT (p-AKT) and AKT. GAPDH and pan-Cadherin serve as loading controls. (b) Lysates of C2C12 cells transiently transfected with Cdo or control expression vectors as indicated were immunoblotted with antibodies to PKN2, Cdo, p-AKT and AKT. GAPDH and pan-Cadherin serve as loading controls. (c) Immunoblot analysis for the expression of PKN2, p-AKT and AKT proteins in Cdo+/+ and Cdo−/− primary myoblasts from hindlimb muscles, and pan-Cadherin serves as a loading control. (d) Photomicrographs of C2C12 cells that stably express PKN2 or control vectors were cultured in DM for 2 days, fixed, and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (e) Quantification of myotube formation shown in (d). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01. (f) C2C12 cells stably transfected with shPKN2 or control (pSuper) vectors, and cultured to confluency and induced to differentiate for total 3 days. Cell lysates were immunoblotted using antibodies to PKN2, MHC, MyoD, Myogenin and pan-Cadherin as a loading control. (g) Photomicrographs of C2C12 cells stably transfected with PKN2 shRNA or control vectors were cultured in DM for 3 days, fixed and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (h) Quantification of myotube formation by cell lines shown in (g). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01 Image collected and cropped by CiteAb from the following publication (https://www.nature.com/articles/cddis2016296), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse CDO by Knockout Validated

Detection of Mouse CDO by Knockout Validated

PKN2 levels are elevated during myoblast differentiation and decreased in Cdo-depleted cells with a concurrent reduction in AKT activation. (a) C2C12 cells were cultured to near confluency (D0) and induced to differentiate in differentiation medium (DM) for total 3 days (D3). Lysates were immunoblotted with antibodies to PKN2, Cdo, MHC, MyoD, myogenin, phosphorylated-AKT (p-AKT) and AKT. GAPDH and pan-Cadherin serve as loading controls. (b) Lysates of C2C12 cells transiently transfected with Cdo or control expression vectors as indicated were immunoblotted with antibodies to PKN2, Cdo, p-AKT and AKT. GAPDH and pan-Cadherin serve as loading controls. (c) Immunoblot analysis for the expression of PKN2, p-AKT and AKT proteins in Cdo+/+ and Cdo−/− primary myoblasts from hindlimb muscles, and pan-Cadherin serves as a loading control. (d) Photomicrographs of C2C12 cells that stably express PKN2 or control vectors were cultured in DM for 2 days, fixed, and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (e) Quantification of myotube formation shown in (d). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01. (f) C2C12 cells stably transfected with shPKN2 or control (pSuper) vectors, and cultured to confluency and induced to differentiate for total 3 days. Cell lysates were immunoblotted using antibodies to PKN2, MHC, MyoD, Myogenin and pan-Cadherin as a loading control. (g) Photomicrographs of C2C12 cells stably transfected with PKN2 shRNA or control vectors were cultured in DM for 3 days, fixed and immunostained with an antibody to MHC followed by DAPI staining to visualize nuclei. Size bar, 100 μm. (h) Quantification of myotube formation by cell lines shown in (g). Values represent means of triplicate determinations ±1 S.D. The experiment was repeated three times with similar results. Significant difference from control, *P<0.01 Image collected and cropped by CiteAb from the following publication (https://www.nature.com/articles/cddis2016296), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Mouse CDO Antibody

Application
Recommended Usage

Immunohistochemistry

5-15 µg/mL
Sample: Immersion fixed frozen sections of mouse embryo (13.5-15.5 d.p.c.)

Western Blot

0.25 µg/mL
Sample: C2C12 mouse myoblast cell line
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CDO

Mouse CDO is a 190 kDa member of the Ig/FN-type III repeat subfamily of transmembrane (TM) proteins. The extracellular region contains five Ig-like domains and three FN-III modules. The molecule forms cis-complexes with itself and the related molecule termed BOC. Mouse CDO extracellular domain shares 95% and 85% aa identity with the corresponding regions of rat and human CDO, respectively.

Long Name

Cell Adhesion Molecule-related/Down-regulated by Oncogenes

Alternate Names

CDON, ORCAM

Entrez Gene IDs

50937 (Human); 57810 (Mouse)

Gene Symbol

CDON

UniProt

Additional CDO Products

Product Documents for Mouse CDO Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Mouse CDO Antibody

For research use only

Loading...
Loading...
Loading...
Loading...